Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression.
about
Oxidative Stress and Antioxidant Defense in Endometriosis and Its Malignant TransformationDown-regulation of GPX3 is associated with favorable/intermediate karyotypes in de novo acute myeloid leukemiaGPX3 promoter is methylated in chronic myeloid leukemia.Evaluation of Matrix Metalloproteinases, Cytokines and Their Potential Role in the Development of Ovarian Cancer.Diagnostic value of serum glutathione peroxidase 3 levels in patients with lung cancer.Positive ALDH1A3 and negative GPX3 expressions are biomarkers for poor prognosis of gallbladder cancerPlasma Markers of Oxidative Stress in Patients with Gestational Diabetes Mellitus in the Second and Third Trimester.GPX3 methylation in bone marrow predicts adverse prognosis and leukemia transformation in myelodysplastic syndromeConstitutive gp130 activation rapidly accelerates the transformation of human hepatocytes via an impaired oxidative stress responseEURRECA-Estimating selenium requirements for deriving dietary reference values.Integrative analysis for the discovery of lung cancer serological markers and validation by MRM-MS.Au Nanoclusters and Photosensitizer Dual Loaded Spatiotemporal Controllable Liposomal Nanocomposites Enhance Tumor Photodynamic Therapy Effect by Inhibiting Thioredoxin Reductase.Glutathione Peroxidase 3 Inhibits Prostate Tumorigenesis in TRAMP Mice.Troglitazone inhibits the migration and invasion of PC-3 human prostate cancer cells by upregulating E-cadherin and glutathione peroxidase 3
P2860
Q26799616-768FB0AD-C2A3-44F2-9890-BE1255256E3EQ35632014-051835E1-4C99-410B-8170-B92E62E9FD10Q35919012-710B68B2-18D3-464F-B075-CEFBBD90C6D6Q36208184-F7C6DAAF-3E17-4E82-BA56-6061D501202AQ36439539-DA4EDC16-010F-4EE2-9FA4-D4F2D95CB98CQ37176623-918BF373-9E08-401E-B9A9-76E46ECB8FA9Q37359754-8D042B9E-60E1-40D6-8AA9-6116CD900199Q37609224-9E58A363-464F-4B70-B406-2FDB7F43A90AQ37688291-6407F524-60FE-4D79-9B5A-93D210824B5EQ38129415-3136654E-B1E5-4C12-B0FB-C90D2D0C8DCDQ41513462-750F6BC2-D060-4B96-BE03-266FC72DD1B7Q46400885-C0C30B4D-0021-43FC-A7F9-E4A278FD0387Q51691612-C9B95F9C-D8A4-43C4-B480-D8AD421DBC4CQ58794883-C3057B04-C397-4C24-9D7F-DE166614B8D3
P2860
Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Decreased levels of serum glut ...... ancer and disease progression.
@ast
Decreased levels of serum glut ...... ancer and disease progression.
@en
type
label
Decreased levels of serum glut ...... ancer and disease progression.
@ast
Decreased levels of serum glut ...... ancer and disease progression.
@en
prefLabel
Decreased levels of serum glut ...... ancer and disease progression.
@ast
Decreased levels of serum glut ...... ancer and disease progression.
@en
P2093
P2860
P356
P1476
Decreased levels of serum glut ...... ancer and disease progression.
@en
P2093
Catalina Camacho
Deep Agnani
John A Martignetti
Olga Camacho-Vanegas
Peter Dottino
Samantha Cohen
Shashi Lele
P2860
P2888
P356
10.1186/1757-2215-4-18
P50
P577
2011-10-22T00:00:00Z
P5875
P6179
1041527570